Loading...
Appropriateness of Apixaban Dosing to Prevent Stroke in Patients with Atrial Fibrillation: A Pilot Study
BACKGROUND: The ARISTOTLE study investigated apixaban, at a dose of 5 mg PO bid, for the prevention of stroke in patients with atrial fibrillation; however, it has been noted anecdotally that many patients are receiving 2.5 mg PO bid, despite being eligible for the full dosage. A recent study examin...
Na minha lista:
| Udgivet i: | Can J Hosp Pharm |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Canadian Society of Hospital Pharmacists
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5242276/ https://ncbi.nlm.nih.gov/pubmed/28123190 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|